CEACAM5 and cholangiocarcinoma: Currently, several CCA markers, such as carbohydrate antigen 19–9 (CA19-9), carcinoembryonic antigen (CEA) and alkaline phosphatase (ALP), are the most widely clinically used biomarkers that have been applied for diagnosis, prognostic stratification, and treatment prediction.